hOX40(BALB/c)

Nomenclature

BALB/cAnSmoc-Tnfrsf4tm1(hTNFRSF4)Smoc

Cat. NO.

NM-HU-233873

Strain State

Repository Live

Export PDF

Gene Summary

Gene Symbol
Tnfrsf4

Model Description

The endogenous mouse Tnfrsf4 gene was replaced by human TNFRSF4 gene.

Validation Data

image.png

Fig.1 Detection of hOX40 expression in CD4+ T cells in Spleen in WT BALB/c and HO hOX40 mice.

Concanavalin A (ConA) was injected by i.v. for 4 hours. Then the splenocyte was activated in vitro by anti-CD3 and anti-CD28, or ConA for 48 hours.

image.png

Fig.2 Detection of hOX40 expression in CD8+ T cells in Spleen in WT BALB/c and HO hOX40 mice.

Concanavalin A (ConA) was injected by i.v. for 4 hours. Then the splenocyte was activated in vitro by anti-CD3 and anti-CD28, or ConA for 48 hours.


You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Workshop:Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

Learn more